To examine the impact of IDH1 mutation and activity on age-dependent glioma outcomes, we implanted GL26 transfected with either wild-type IDH1 or IDH1R132H into young and old syngeneic C57BL/6 (B6) mice. Here, IDH1 is linked to central nervous system cancer.